06| Pediatric Cancer: The Role of a Neuropsychologist (Part 2)


In Part 2 of Pediatric Cancer, we discuss the following topics with Dr. Christine Trask (see the show notes for Part 1 for Christine’s bio):

  • Issues pertaining to neuropsychological testing with pediatric cancer patients
    • Is it necessary to postpone testing until after acute cancer treatment?
    • How to account for academic factors when scheduling the testing session
    • The neuropsychological battery in pediatric oncology – which cognitive domains should we focused on?
    • Other environmental considerations (e.g., disinfecting test materials to protect immunocompromised children)
  • Effects of high degrees of childhood neuroplasticity on cognitive outcomes following localized brain tumors
  • The academic effects of cancer symptoms and treatment
  • Neuropsychological recommendations for children with cancer
    • Processing speed and executive functioning recommendations
    • Academic accommodations and collaborating with school systems
    • The utility of psychostimulants and cognitive remediation
  • Neuropsychological report writing for multiple consumers (physician, parent, teacher, etc.)
  • How to deliver neuropsychological feedback to parents and when to consider providing feedback to the child/adolescent
  • Differences in the cognitive effects of cancer treatments in adults compared to children
  • Chemo brain and… “radiation brain?”
  • Longitudinal investigations of survivors of childhood cancer
  • Training in pediatric oncology for students of neuropsychology
  • Biggest challenges to working with this population







Kahalley LS, Conklin HM, Tyc VL, Hudson MM, Wilson SJ, Wu S, Xiong X, & Hinds PS (2013). Slower processing speed after treatment for pediatric brain tumor and acute lymphoblastic leukemia. Psychooncology.

Cheung YT & Krull KR. Neurocognitive outcomes in long-term survivors of childhood acute lymphoblastic leukemia treated on contemporary treatment protocols: A systematic review (2015). Neurosci Biobehav Rev.

Liu W, Cheung YT, Conklin HM, Jacola LM, Srivastava D, Nolan VG, Zhang H, Gurney JG, Huang IC, Robison LL, Pui CH, Hudson MM, & Krull KR (2018). Evolution of neurocognitive function in long-term survivors of childhood acute lymphoblastic leukemia treated with chemotherapy only.  J Cancer Surviv.

Iyer NS, Balsamo LM, Bracken MB, Kadan-Lottick NS (2015).  Chemotherapy-only treatment effects on long-term neurocognitive functioning in childhood ALL survivors: a review and meta-analysis.  Blood.


(note: we have no affiliation with these sites and have no financial incentives to disclose)


Leave a Reply

Your email address will not be published. Required fields are marked *